Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple arm exercise may boost lung recovery after colon cancer surgery in seniors

NCT ID NCT06876961

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 20-minute arm cycling exercise, done twice daily for five days, could improve lung function and recovery in 60 elderly patients after colon cancer surgery. Participants also received standard physical therapy. The goal was to see if the arm exercise could help with breathing, oxygen levels, and overall physical function in the intensive care unit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
arm cycling exercise
What this could lead to
If it works, this could point toward a simple, drug-free way to help elderly patients recover lung function and physical ability after colon surgery.
What could go wrong
This is a small, completed trial with only 60 male participants, so results may not apply to all patients. The exercise is an add-on to standard care, not a standalone treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Sixty male patients who received a surgical removal of a diagnosed colon cancer (i.e., including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy) will be included. 2. Patients with a histologically confirmed diagnosis of primary colon or rectal neoplasm. 3. Colectomy isolated surgeries. 4. Patients will be included in this study after the immediate admission to the intensive care unit. 5. The age of patients will be ≥ 65 years old. 6. Patients' body mass index will be \< 30 Kg/m2. 7. All patients will be conscious, medically stable, and able to respond to the given commands fully. 8. Patients who voluntarily cooperated with this study 9. Karnofsky Performance Status \> 60 and able to walk ≥ 60 m. The Karnosky Performance Status is one of the most used validated scales to define the functional status of a cancer patient. A Karnofsky Performance Status ≤ 60 indicates the inability to work and severe difficulty in carrying out activities of daily living and personal care of the cancer patient Before surgeries Exclusion Criteria: Men who will meet one of the following criteria will be excluded: 1. relapsing cancer or metastasis cancer; simultaneous diagnosis of other neoplasms. 2. Cardiac disease patients. 3. Chronic inflammatory autoimmune disease 4. Patients with neurological conditions limit the performance of exercises. 5. Patients with diagnosed psychogenic diseases. 6. Patients with musculoskeletal disorders that interfere with performing exercise programs. 7. Chronic obstructive pulmonary disease, Asthma, hemodynamically unstable, significant arrhythmias, and any chronic lung disease. 8. Patients require invasive/noninvasive ventilatory support. 9. regular use of immunosuppressive drugs. 10. Patients with cognitive disorders and unstable hemodynamics. 11. patients suffering from brain death; or respiratory failure; ventilator-dependent patients: patients receiving palliative care or patients on tracheostomy. 12. inability to understand given information due to language or intellectual barriers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arm cycle ergometer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King Hamad University Hospital,

    Al Muharraq, Bahrain

More trials for these conditions

Other studies related to the condition(s) this trial covers.